Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma

Key Points

• The aim is to evaluate microRNA-192's ability to predict liver cirrhosis and hepatocellular carcinoma.
• Assessed serum microRNA-192 levels in patients with liver conditions.
• Used sensitivity and specificity analyses to evaluate diagnostic performance.
• MicroRNA-192 demonstrated high sensitivity in predicting liver cirrhosis.
• The specificity of microRNA-192 for hepatocellular carcinoma was also high.